Group I mGluR agonist-evoked long-term potentiation in hippocampal oriens interneurons

J Neurosci. 2011 Apr 13;31(15):5777-81. doi: 10.1523/JNEUROSCI.6265-10.2011.

Abstract

Several subtypes of interneurons in the feedback circuit in stratum oriens of the hippocampus exhibit NMDA receptor-independent long-term potentiation (LTP) at glutamatergic synapses made by local pyramidal neurons. LTP has been reported with both "Hebbian" and "anti-Hebbian" induction protocols, where high-frequency presynaptic stimulation is paired with either postsynaptic depolarization or hyperpolarization. Do these phenomena represent distinct forms of plasticity, dependent on group I metabotropic receptors (mGluRs) and rectifying Ca2+ -permeable AMPA receptors, respectively? Blockade of either mGluR1 or mGluR5 prevented anti-Hebbian LTP induction in stratum oriens interneurons in rat hippocampal slices. Exogenous activation of group I mGluRs by the selective agonist (S)-3,5-dihydroxyphenylglycine (DHPG) was unable to induce LTP on its own, and instead depressed excitatory transmission. However, when paired with postsynaptic hyperpolarization, DHPG or the group I metabotropic receptor (mGluR5)-selective agonist (R,S)-2-chloro-5-hydroxyphenylglycine (CHPG) elicited a delayed long-lasting potentiation, which was accompanied by a decrease in paired-pulse facilitation. Anti-Hebbian LTP occluded the effect of DHPG paired with hyperpolarization, implying that the induction cascades triggered by both conjunctions of stimuli converge on common expression mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzoates / pharmacology
  • Electric Stimulation
  • Electrodes, Implanted
  • Electrophysiological Phenomena
  • Excitatory Amino Acid Agonists / pharmacology*
  • Excitatory Postsynaptic Potentials / drug effects
  • Glycine / analogs & derivatives
  • Glycine / pharmacology
  • Hippocampus / cytology
  • Hippocampus / drug effects*
  • Interneurons / drug effects*
  • Long-Term Potentiation / drug effects*
  • Male
  • Phenylacetates / pharmacology
  • Pyridines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, AMPA / drug effects
  • Receptors, Metabotropic Glutamate / agonists*
  • Resorcinols / pharmacology

Substances

  • 2-chloro-5-hydroxyphenylglycine
  • Benzoates
  • Excitatory Amino Acid Agonists
  • Phenylacetates
  • Pyridines
  • Receptors, AMPA
  • Receptors, Metabotropic Glutamate
  • Resorcinols
  • metabotropic glutamate receptor type 1
  • alpha-methyl-4-carboxyphenylglycine
  • 3,5-dihydroxyphenylglycine
  • 6-methyl-2-(phenylethynyl)pyridine
  • Glycine